TY  - GEN
AU  - Wu,Xinqi
AU  - Giobbie-Hurder,Anita
AU  - Liao,Xiaoyun
AU  - Lawrence,Donald
AU  - McDermott,David
AU  - Zhou,Jun
AU  - Rodig,Scott
AU  - Hodi,F Stephen
TI  - VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma
SN  - 2326-6074
PY  - 2018///0116
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Neoplasm
KW  - biosynthesis
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - administration & dosage
KW  - CTLA-4 Antigen
KW  - antagonists & inhibitors
KW  - Cell Adhesion
KW  - immunology
KW  - Chemokine CXCL10
KW  - genetics
KW  - Chemokines
KW  - blood
KW  - Cytokines
KW  - Female
KW  - Humans
KW  - Intercellular Adhesion Molecule-1
KW  - metabolism
KW  - Ipilimumab
KW  - Lymphocytes, Tumor-Infiltrating
KW  - drug effects
KW  - Male
KW  - Melanoma
KW  - drug therapy
KW  - Middle Aged
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - Tumor Cells, Cultured
KW  - Tumor Microenvironment
KW  - Tumor Necrosis Factor-alpha
KW  - Up-Regulation
KW  - Vascular Cell Adhesion Molecule-1
N1  - Publication Type: Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1158/2326-6066.CIR-16-0084
ER  -